Fulgent Genetics Inc
NASDAQ:FLGT

  • LAST PRICE
    17.8700
  • TODAY'S CHANGE (%)
    0.9200 (5.4277%)
  • Bid / Lots
    17.5500/ 1
  • Ask / Lots
    18.1000/ 1
  • Open / Previous Close
    17.1000 / 16.9500
  • Day Range
    17.0600
    17.9499
  • 52 Week Range
    16.5600
    30.6800
  • Volume
    422,846

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Healthcare Facilities Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
FLGT
Fulgent Genetics Inc
518.4M
-3.2x
---
CHTH
CNL Healthcare Properties Inc
487.4M
-35.0x
---
SNDA
Sonida Senior Living Inc
467.2M
-11.7x
---
CHCT
Community Healthcare Trust Inc
523.3M
-160.8x
+1.34%
TALK
Talkspace Inc
559.1M
-406.4x
---
UHT
Universal Health Realty Income Trust
563.0M
31.0x
-8.76%
As of 2024-11-22

Company Information

Fulgent Genetics, Inc. is a technology-based genetic company with a laboratory services business and a therapeutic development business. The Company’s laboratory services business includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform designed to improve the therapeutic window and pharmacokinetic profile (PK) profile of new and existing cancer drugs. Its technology platform for its laboratory services business includes gene probes, data suppression and comparison algorithms, learning software, and laboratory information management systems. The platform provides a test menu, the ability to rapidly develop and launch new tests and customizable test offerings. The Company also offers next-generation sequencing (NGS) services.

Contact Information

Headquarters
4399 SANTA ANITA AVEEL MONTE, CA, United States 91731
Phone
626-350-0537
Fax
626-454-1667

Executives

Chairman of the Board, Chief Executive Officer
Ming Hsieh
President, Chief Operating Officer
Jian Xie
Chief Financial Officer
Paul Kim
Chief Scientific Officer, Laboratory Director
Hanlin Gao
Independent Director
Regina Groves

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
$518.4M
Revenue (TTM)
$277.8M
Shares Outstanding
30.6M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.44
EPS
$-5.53
Book Value
$38.31
P/E Ratio
-3.2x
Price/Sales (TTM)
1.9
Price/Cash Flow (TTM)
---
Operating Margin
-78.84%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.